MedTrace Logo

Laser Verses Conventional Circumferential Supracrestal Fiberotomy in Orthodontic Extrusion for Crown Lengthening

NCT06221137 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-02-28

No results posted yet for this study

Summary

The aim of this study is to the evaluate the stability of the amount of healthy tooth structure exposed after laser versus conventional technique of fiberotomy during orthodontic extrusion.

Conditions

  • Circumferential Supracrestal Fiberotomy
  • Orthodontic Extrusion
  • Crown Lengthening

Interventions

PROCEDURE

conventional circumferential supracrestal fiberotomy

The amount of tooth that need to be extruded will be measured Bonding brackets slot 0,022"x0.028" Roth prescription on piggyback for the tooth with (0.016". x 0.022 ") stainless steel main arch wire and 0.0014" nickel titanium auxiliary. • Fiberotomy After 2 days of bonding, local anaesthetic solution will be administrated. The depth of the fibrotomy should be equal to the amount of tooth that need to be extruded. supracrustal fibrotomy will be performed using 15 c blade (Carvalho, Bauer et al. 2006)

PROCEDURE

laser circumferential supracrestal fiberotomy

* The amount of tooth that need to be extruded will be measured * Bonding brackets slot 0,022"x0.028" Roth prescription * piggyback for the tooth with (0.016". x 0.022 ") stainless steel main arch wire and 0.0014" nickel titanium auxiliary. • Fiberotomy * After 2 days of bonding, local anaesthetic solution will be administrated. * The depth of the fibrotomy should be equal to the amount of tooth that need to be extruded. * A diode laser of 980 nm wavelength will be used The laser tip will be inserted, and incision will be extended around tooth circumference with the system configured to a continuous wave with the movement of the laser tip in an up and down stroking movement The laser tip will be moved in a circumferential manner taking care that all the fibers are lysed.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Nesma M Shemais, PhD · Cairo University

  • Heba A Akl, PhD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-06-30
Completion
2024-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06221137 on ClinicalTrials.gov